Wu Di - Net Worth and Insider Trading
Wu Di Net Worth
The estimated net worth of Wu Di is at least $2 Million dollars as of 2025-04-02. Wu Di is the Executives of Realcan Pharmaceutical Group Co Ltd and owns about 540,600 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) stock worth over $2 Million. Details can be seen in Wu Di's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wu Di has not made any transactions after 2018-12-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wu Di
Wu Di Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Di owns 1 companies in total, including Realcan Pharmaceutical Group Co Ltd (SZSE:002589) .
Click here to see the complete history of Wu Di’s form 4 insider trades.
Insider Ownership Summary of Wu Di
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SZSE:002589 | Realcan Pharmaceutical Group Co Ltd | 2018-12-26 | Executives |
Wu Di Latest Holdings Summary
Wu Di currently owns a total of 1 stock. Wu Di owns 540,600 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) as of December 26, 2018, with a value of $2 Million.
Latest Holdings of Wu Di
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SZSE:002589 | Realcan Pharmaceutical Group Co Ltd | 2018-12-26 | 540,600 | 3.11 | 1,681,266 |
Holding Weightings of Wu Di
Wu Di Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Di has made a total of 0 transactions in Realcan Pharmaceutical Group Co Ltd (SZSE:002589) over the past 5 years. The most-recent trade in Realcan Pharmaceutical Group Co Ltd is the acquisition of 80,900 shares on December 26, 2018, which cost Wu Di around $557,401.
Insider Trading History of Wu Di
- 1
Wu Di Trading Performance
GuruFocus tracks the stock performance after each of Wu Di's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Di is -12.33%. GuruFocus also compares Wu Di's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Di within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Di's insider trading performs compared to the benchmark.
Wu Di Ownership Network
Ownership Network List of Wu Di
Ownership Network Relation of Wu Di

Wu Di Owned Company Details
What does Realcan Pharmaceutical Group Co Ltd do?
Who are the key executives at Realcan Pharmaceutical Group Co Ltd?
Wu Di is the Executives of Realcan Pharmaceutical Group Co Ltd. Other key executives at Realcan Pharmaceutical Group Co Ltd include Directors & executives Zhang Ren Hua , Directors & Directors & and Executives Zhou Yun , and Executives Su Li Chen .
Realcan Pharmaceutical Group Co Ltd (SZSE:002589) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Realcan Pharmaceutical Group Co Ltd (SZSE:002589) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Realcan Pharmaceutical Group Co Ltd (SZSE:002589)'s detailed insider trading history can be found in Insider Trading Tracker table.
Realcan Pharmaceutical Group Co Ltd Insider Transactions
Wu Di Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Di. Currently GuruFocus does not have mailing address information for Wu Di.